Screener / SEC EDGAR /CIK 0001822479 /10-K filed Feb 24, 2026, compared with Feb 27, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Health Services

Sotera Health Co SHC

Compare with peers Embed
What it said it expected, against what it reported

2 targets with a reported result

Releases of the last 3 years
Above the range 1 above the last range given
Within the range 1 of 2 range targets
Below the range 0 below the last range given

The numbers SHC said it expected, in its earnings releases, next to what it then reported for the same period.

Target by target

Each target, with the sentence it came from · release and 10-Q or 10-K

The last range givenReported, abovewithin or keptbelow or missed
TargetWhat the company saidReportedResult
EBITDA (company-defined)
Fiscal 2026
Given $632.00M to $641.00M release Feb 24, 2026
Kept $632.00M to $641.00M release May 5, 2026
Raised $634.00M to $643.00M release Aug 6, 2026
Lowered $632.00M to $641.00M release Nov 3, 2026
– No standard number
The company's words
Full-Year 2026 Outlook … Adjusted EBITDA in the range of $632 million to $641 million, representing constant currency growth of 5.5% to 7.0% and an estimated 100bps foreign currency benefit release Feb 24, 2026
The 2026 outlook below, first provided on February 24, 2026, remains unchanged: … Adjusted EBITDA in the range of $632 million to $641 million, representing constant currency growth of 5.5% to 7.0% and an estimated 100bps foreign currency benefit release May 5, 2026
Today, Sotera Health is raising its 2026 outlook: … Adjusted EBITDA range raised to $634 million to $643 million, representing constant currency growth of 5.75% to 7.25% and an estimated 100 basis points of foreign currency benefit release Aug 6, 2026
Full-Year 2026 Outlook … Adjusted EBITDA in the range of $632 million to $641 million, representing constant currency growth of 5.75% to 7.25%. release Nov 3, 2026
Capital expenditures
Fiscal 2026
Given $175.00M to $225.00M release Feb 24, 2026
Kept $175.00M to $225.00M release May 5, 2026
Raised $200.00M to $225.00M release Aug 6, 2026
Kept $200.00M to $225.00M release Nov 3, 2026
– Not reported yet
The company's words
Full-Year 2026 Outlook … Capital expenditures in the range of $175 million to $225 million release Feb 24, 2026
The 2026 outlook below, first provided on February 24, 2026, remains unchanged: … Capital expenditures in the range of $175 million to $225 million release May 5, 2026
Today, Sotera Health is raising its 2026 outlook: … Capital expenditures in the range of $200 million to $225 million release Aug 6, 2026
Full-Year 2026 Outlook … Capital expenditures remain in the range of $200 million to $225 million. release Nov 3, 2026
Diluted EPS (company-defined)
Fiscal 2026
Given $0.93 to $1.01 release Feb 24, 2026
Kept $0.93 to $1.01 release May 5, 2026
Raised $0.95 to $1.01 release Aug 6, 2026
Kept $0.95 to $1.01 release Nov 3, 2026
– No standard number
The company's words
Full-Year 2026 Outlook … Adjusted EPS in the range of $0.93 to $1.01 release Feb 24, 2026
The 2026 outlook below, first provided on February 24, 2026, remains unchanged: … Adjusted EPS in the range of $0.93 to $1.01 release May 5, 2026
Today, Sotera Health is raising its 2026 outlook: … Adjusted EPS improved to a range of $0.95 to $1.01 release Aug 6, 2026
Full-Year 2026 Outlook … Adjusted EPS range remains in the range of $0.95 to $1.01. release Nov 3, 2026
Revenue
Fiscal 2026
Given $1.23B to $1.25B release Feb 24, 2026
Kept $1.23B to $1.25B release May 5, 2026
Raised $1.24B to $1.25B release Aug 6, 2026
Lowered $1.23B to $1.25B release Nov 3, 2026
– Not reported yet
The company's words
Full-Year 2026 Outlook … Net revenues in the range of $1.233 billion to $1.251 billion, representing constant currency growth of 5.0% to 6.5% and an estimated 100bps foreign currency benefit release Feb 24, 2026
The 2026 outlook below, first provided on February 24, 2026, remains unchanged: … Net revenues in the range of $1.233 billion to $1.251 billion, representing constant currency growth of 5.0% to 6.5% and an estimated 100bps foreign currency benefit release May 5, 2026
Today, Sotera Health is raising its 2026 outlook: … Net revenues range raised to $1.236 billion to $1.254 billion, representing constant currency growth of 5.25% to 6.75% and an estimated 100 basis points of foreign currency benefit release Aug 6, 2026
Full-Year 2026 Outlook … Net revenues in the range of $1.233 billion to $1.250 billion, representing constant currency growth of 5.25% to 6.75%. release Nov 3, 2026
Capital expenditures
Fiscal 2025 (ended Dec 31, 2025)
Given $190.00M to $210.00M release Feb 27, 2025
Lowered $170.00M to $180.00M release Aug 8, 2025
Lowered $125.00M to $135.00M release Nov 4, 2025
$138.02M
10-K filed 2026-02-24
Above the range
The company's words
Today, Sotera Health is providing its full-year 2025 outlook: … Capital expenditures in the range of $190 million to $210 million, release Feb 27, 2025
Sotera Health is providing an update to its full-year 2025 outlook: … Capital expenditures are now expected to be in the range of $170 million to $180 million, from previous outlook of $190 million to $210 million. release Aug 8, 2025
Today, Sotera Health is updating its 2025 outlook: … Capital expenditures in the range of $125 million to $135 million, from a previous outlook of $170 million to $180 million. release Nov 4, 2025
Diluted EPS (company-defined)
Fiscal 2025 (ended Dec 31, 2025)
Given $0.70 to $0.76 release Feb 27, 2025
Raised $0.75 to $0.82 release Aug 8, 2025
Raised $0.81 to $0.86 release Nov 4, 2025
– No standard number
The company's words
Today, Sotera Health is providing its full-year 2025 outlook: … Adjusted EPS in the range of $0.70 to $0.76, release Feb 27, 2025
Sotera Health is providing an update to its full-year 2025 outlook: … Adjusted EPS range raised to $0.75 - $0.82 from $0.70 - $0.76, release Aug 8, 2025
Today, Sotera Health is updating its 2025 outlook: … Adjusted EPS range raised to $0.81 to $0.86, from a previous outlook of $0.75 to $0.82, release Nov 4, 2025
Capital expenditures
Fiscal 2024 (ended Dec 31, 2024)
Given $205.00M to $225.00M release Feb 27, 2024
Lowered $175.00M to $185.00M release Nov 5, 2024
$179.07M
10-K filed 2025-02-27
Within the range
The company's words
Today, Sotera Health is providing its full-year 2024 outlook: … Capital expenditures in the range of $205 million to $225 million release Feb 27, 2024
The following range in the 2024 outlook is being updated: … Capital expenditures are now expected to be in the range of $175 million to $185 million, from previous guidance of $205 million to $225 million release Nov 5, 2024
Diluted EPS (company-defined)
Fiscal 2024 (ended Dec 31, 2024)
Given $0.67 to $0.75 release Feb 27, 2024
Kept $0.67 to $0.75 release Nov 5, 2024
– No standard number
The company's words
Today, Sotera Health is providing its full-year 2024 outlook: … Adjusted EPS in the range of $0.67 to $0.75, release Feb 27, 2024
Today, Sotera Health is reaffirming the following 2024 outlook ranges previously provided: … Adjusted EPS in the range of $0.67 to $0.75, release Nov 5, 2024

Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (15 releases since 2024-01-09), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.

Sources

The outlook sentences of each earnings release (8-K item 2.02, exhibit 99), read without AI; results from SEC's XBRL company facts, as first reported.

Also

Earnings releases: each release in full.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/SHC/export.csv") into a cell.

Next:Archive
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.